• TH
    • EN
    • Register
    • Login
    • Forgot Password
    • Help
    • Contact
  • Register
  • Login
  • Forgot Password
  • Help
  • Contact
  • EN 
    • TH
    • EN
View Item 
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Research Reports
  • View Item
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Research Reports
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Medicine Prices Situation Survey in Thailand and Design the Pricing Policy

ชะอรสิน สุขศรีวงศ์; Chaoncin Sooksriwong; ศนิตา หิรัญรัศมี; Sanita Hirunrassamee; กุสาวดี เมลืองนนท์; Kusawadee Maluangnon; สิริวัฒน์ สุวัฒนปรีดา; Siriwat Suwattanapreeda; ถิรพิชญ์ เจือจันทร์; Thirapich Chuachantra;
Date: 2567-06
Abstract
Background: In Thailand, since the first report 16 years ago, the Thai FDA has established several committees to address drug pricing issues. However, there is a lack of comprehensive documentation on the progress and effectiveness of these committees, which is crucial for developing and managing Thailand's drug pricing policy. Objectives: This study aims to evaluate the current drug pricing situation in Thailand and develop policy recommendations to enhance the drug pricing system. Specific objectives include assessing drug prices in public and private sectors, analyzing pricing structures, and evaluating the availability of essential medicines. Methods: A cross-sectional survey was conducted using WHO/Health Action International (HAI) methodology. Data collection focused on the availability and affordability of medicines in various healthcare settings, including public and private sectors. Results: Public Sector: Innovator brands were procured at nearly twice their international reference prices, and generics at lower than reference prices. Public sector patient prices showed significant markups. Private Sector: Innovator brands were sold at 6.40 times and generics at 4.71 times their international reference prices. Availability: Essential medicines had variable availability rates, with some widely accessible and others less so. Price Components: Imported drug prices included significant margins at each stage from manufacturing to consumer. Affordability: Most drugs were affordable, except for high-cost items like Epoetin alfa injection. International Comparison: Many drugs in Thailand were cheaper than in other countries, but some generics were more expensive. Conclusions: The study highlights key issues in drug pricing and availability in Thailand. It recommends that policymakers establish an institute to regularly monitor and report drug price index. Additionally, it suggests developing an appropriate drug pricing policy to regulate prices throughout the supply chain.
Copyright ผลงานวิชาการเหล่านี้เป็นลิขสิทธิ์ของสถาบันวิจัยระบบสาธารณสุข หากมีการนำไปใช้อ้างอิง โปรดอ้างถึงสถาบันวิจัยระบบสาธารณสุข ในฐานะเจ้าของลิขสิทธิ์ตามพระราชบัญญัติสงวนลิขสิทธิ์สำหรับการนำงานวิจัยไปใช้ประโยชน์ในเชิงพาณิชย์
Fulltext
Thumbnail
Name: he0152.pdf
Size: 1.734Mb
Format: PDF
Download

User Manual
(* In case of download problems)

Total downloads:
Today: 0
This month: 0
This budget year: 3
This year: 0
All: 5
 

 
 


 
 
Show full item record
Collections
  • Research Reports [2469]

    งานวิจัย


DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

HSRI Knowledge BankDashboardCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjectsSubjectsการบริการสุขภาพ (Health Service Delivery) [619]กำลังคนด้านสุขภาพ (Health Workforce) [99]ระบบสารสนเทศด้านสุขภาพ (Health Information Systems) [286]ผลิตภัณฑ์ วัคซีน และเทคโนโลยีทางการแพทย์ (Medical Products, Vaccines and Technologies) [125]ระบบการเงินการคลังด้านสุขภาพ (Health Systems Financing) [158]ภาวะผู้นำและการอภิบาล (Leadership and Governance) [1281]ปัจจัยสังคมกำหนดสุขภาพ (Social Determinants of Health: SDH) [228]วิจัยระบบสุขภาพ (Health System Research) [28]ระบบวิจัยสุขภาพ (Health Research System) [20]

DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV